MCUJF Medicure Inc.
Medicure Inc. (MCUJF) is expected to report earnings on November 12, 2026, after the market close.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Medicure Inc.
Medicure Inc is a cardiovascular drug discovery and development company focused on developing effective therapeutics for unmet needs in the field of cardiovascular medicine. In addition to MC-4232, they are also conducting Phase II clinical trials with MC-1, which is focused on the prevention and treatment of ischemia, ischemic reperfusion injury, and stroke.
Charts powered in part by Lightweight Charts™ by TradingView.